德隆
泛素连接酶
细胞生物学
泛素
DNA连接酶
RNA剪接
蛋白酶体
HEK 293细胞
选择性拼接
化学
泛素蛋白连接酶类
生物
突变体
生物化学
受体
信使核糖核酸
基因
核糖核酸
作者
Dirksen E. Bussiere,Lili Xie,Srinivas Honnappa,Wei Shu,Ashley Burke,C. Be,Junping Zhao,Adarsh Godbole,Dan King,Rajeshri G. Karki,Viktor Horn̆ák,Fangmin Xu,Jennifer Cobb,Nathalie Carte,Andreas O. Frank,Alexandra Frommlet,Patrick Graff,Mark Knapp,Aleem Fazal,Okram Barun
标识
DOI:10.1038/s41589-019-0411-6
摘要
The anticancer agent indisulam inhibits cell proliferation by causing degradation of RBM39, an essential mRNA splicing factor. Indisulam promotes an interaction between RBM39 and the DCAF15 E3 ligase substrate receptor, leading to RBM39 ubiquitination and proteasome-mediated degradation. To delineate the precise mechanism by which indisulam mediates the DCAF15-RBM39 interaction, we solved the DCAF15-DDB1-DDA1-indisulam-RBM39(RRM2) complex structure to a resolution of 2.3 Å. DCAF15 has a distinct topology that embraces the RBM39(RRM2) domain largely via non-polar interactions, and indisulam binds between DCAF15 and RBM39(RRM2), coordinating additional interactions between the two proteins. Studies with RBM39 point mutants and indisulam analogs validated the structural model and defined the RBM39 α-helical degron motif. The degron is found only in RBM23 and RBM39, and only these proteins were detectably downregulated in indisulam-treated HCT116 cells. This work further explains how indisulam induces RBM39 degradation and defines the challenge of harnessing DCAF15 to degrade additional targets.
科研通智能强力驱动
Strongly Powered by AbleSci AI